Recent News for CFMS - ConforMIS, Inc.

Date Title
Apr 16 Globus Medical (GMED) Simplifies Spine Surgery With CREO ONE
Apr 7 Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
Apr 6 Orthofix (OFIX) Wins FDA Clearance for CONSTRUX Mini Ti System
Mar 26 Varian Medical (VAR) Hits 52-Week High: What's Driving It?
Mar 19 Conformis: Caution Warranted Following Another Underwhelming Quarter
Mar 16 Conformis highlights cost effectiveness of its knee replacement technology
Mar 16 Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now
Mar 16 Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants
Mar 15 ConforMIS (CFMS) Upgraded to Buy: Here's What You Should Know
Mar 4 Conformis, Inc. (CFMS) CEO Mark Augusti on Q4 2020 Results - Earnings Call Transcript
Mar 3 ConforMIS (CFMS) Reports Q4 Loss, Misses Revenue Estimates
Mar 3 ConforMIS EPS beats by $0.02, revenue in-line
Mar 3 Conformis, Inc. Reports Fourth Quarter and Year End 2020 Financial Results
Mar 3 Earnings Scheduled For March 3, 2021
Mar 2 Conformis's Earnings Outlook
Mar 2 Conformis shares surge on iTotal PS clearance in Australia
Mar 1 Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
Feb 22 Shares rise as Conformis wins FDA 510(k) approval for knee replacement systems
Feb 12 Conformis plummets 17% on capital raise
Feb 12 Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
Feb 12 Conformis down 10% on launch of stock offering
Feb 11 Conformis, Inc. Announces Proposed Public Offering of Common Stock
Feb 5 Conformis'(NASDAQ:CFMS) Share Price Is Down 86% Over The Past Five Years.
Jan 21 Conformis and SITES Medical collaborate for cementless total knee technology
Jan 21 Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
Back to the Main CFMS Page...